You are here

Pfizer

Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September

Fierce Pharma

Mon, 10/9/17 - 11:24 am

[video+transcript]Is This How Drugmakers Will Kill Biosimilars?

Motley Fool

Tue, 10/3/17 - 11:40 am

Does Pfizer really want Bristol-Myers? Likely, says one analyst. What's it waiting for?

Fierce Pharma

Mon, 10/2/17 - 10:19 pm

Bristol-Myers Squibb

Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval

Fierce Pharma

Thu, 09/28/17 - 06:24 pm

Pfizer is falling short in a competitive market, Johnson & Johnson says as it hits back at Remicade biosimilar suit

Fierce Pharma

Tue, 09/26/17 - 09:39 pm

In A First, Pfizer Spins Out Biotech Firm With $103 Million In Funding

Forbes

Mon, 09/25/17 - 09:52 am

SpringWorks Therapeutics

Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst

Fierce Pharma

Thu, 09/21/17 - 10:18 pm

Pfizer hits a snag in bid to jump-start Sutent's flagging kidney cancer sales

Fierce Pharma

Thu, 09/21/17 - 10:02 pm

Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod

Yahoo/Reuters

Thu, 09/21/17 - 08:38 am

Merkel cell carcinoma

This squabble between two big drugmakers could have major implications for the U.S. health care system

Marketwatch

Thu, 09/21/17 - 08:36 am

3 Ways AI Is Changing Medicine

Motley Fool

Thu, 09/21/17 - 08:30 am

artificial intelligence

Gritstone Oncology

cancer immunotherapy

retinal blindness

Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag

Fierce Pharma

Wed, 09/20/17 - 11:08 pm

emerging markets

Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar

First Word Pharma

Wed, 09/20/17 - 11:03 am

Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars

Drug Channels

Wed, 09/20/17 - 09:05 am

New PhIII data in hand, Pfizer, Astellas hustle ahead in bid to expand US market for Xtandi

Endpoints

Thu, 09/14/17 - 10:27 am

clinical trials

prostate cancer

Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates

Fierce Pharma

Tue, 09/12/17 - 09:47 pm

AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend

Fierce Pharma

Mon, 09/11/17 - 09:06 pm

Allergan's Patent Loophole Could Be a Huge Gift for Pfizer

Motley Fool

Mon, 09/11/17 - 09:54 am

#ESMO17: Eli Lilly sets the stage for a CDK 4/6 showdown with Pfizer, Novartis — but not exactly to its advantage

Endpoints

Mon, 09/11/17 - 09:17 am

FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar

RAPS.org

Fri, 09/8/17 - 09:28 am

Pages